Comparative evaluation of clinical glycemic control markers treated with imeglimin and its effect on erythrocytes in patients with type 2 diabetes mellitus: study protocol of a single-arm, open-label, prospective, exploratory trial

Background: Imeglimin is a novel type 2 diabetes (T2D) drug that is expected to improve mitochondrial function. In its phase 3 clinical trials in Japanese patients with T2D, the hemoglobin A1c (HbA1c) decrease following imeglimin administration was slow, reaching a plateau after 20-24 weeks of treat...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
मुख्य लेखकों: Takeshi Osonoi (लेखक), Shinichiro Shirabe (लेखक), Miyoko Saito (लेखक), Mitsuru Hosoya (लेखक), Satako Douguchi (लेखक), Kensuke Ofuchi (लेखक), Makoto Katoh (लेखक)
स्वरूप: पुस्तक
प्रकाशित: Frontiers Media S.A., 2023-06-01T00:00:00Z.
विषय:
ऑनलाइन पहुंच:Connect to this object online.
टैग: टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

इंटरनेट

Connect to this object online.

3rd Floor Main Library

होल्डिंग्स विवरण से 3rd Floor Main Library
बोधानक: A1234.567
प्रति 1 उपलब्ध